Skip to main content
Device/Product Name
Libtayo
Active ingredients
Cemiplimab
AusPAR Date
Published
Submission Number
PM-2020-06003-1-4
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site